You just read:

Regen BioPharma, Inc. Sees Additional Positive Results on its Medicinal Chemistry Optimization for Modulating NR2F6 Checkpoint for Treating Cancer and Autoimmune Diseases

News provided by

Regen BioPharma, Inc.

May 16, 2017, 08:00 ET